Photon-Counting and Dual-Energy CT Imaging and Spectral Analysis
This community develops and evaluates advanced X-ray imaging technologies, specifically photon-counting detectors and dual-energy systems, to improve diagnostic accuracy and reduce radiation exposure in clinical settings.
The research focuses heavily on the technical implementation of photon-counting computed tomography (PCCT) and dual-energy CT, analyzing their impact on image quality, radiation dose, and spectral data acquisition. Recurring themes include the use of deep learning for image reconstruction, the quantification of iodine concentration for contrast enhancement, and the application of virtual monoenergetic imaging. While the primary focus is on oncological applications—such as lung cancer, squamous cell carcinoma, and lymph node evaluation—the community also includes a distinct strand of work on calcium pyrophosphate deposition disease, utilizing spectral imaging to differentiate crystal types. The work bridges detector physics, algorithmic reconstruction, and clinical diagnostic performance.
The largest share of the community's output is found in selenium research, accounting for 2.6% of all selenium research, and 1,408 papers here. Iodine research also features prominently, with 1.6% of its research appearing in this group, comprising 1,314 papers.
The community comprises 14,866 papers, published most frequently in the Journal of the Optical Society of America, Medical Physics, and Physics in Medicine and Biology.
Recent work continues to compare the spectral performance of dual-energy and photon-counting scanners, including studies on reducing contrast media dosage for pulmonary embolism and using iodine maps to predict microsatellite instability in colorectal cancer.